Khalili, Azadeh, Alipour, Shohreh, Fathalipour, Mohammad, Purkhosrow, Azar, Mashghoolozekr, Elaheh, Bayat, Gholamreza, Nekooeian, Ali Akbar. (1398). Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats. سامانه مدیریت نشریات علمی, 45(1), 41-49. doi: 10.30476/ijms.2019.45310
Azadeh Khalili; Shohreh Alipour; Mohammad Fathalipour; Azar Purkhosrow; Elaheh Mashghoolozekr; Gholamreza Bayat; Ali Akbar Nekooeian. "Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats". سامانه مدیریت نشریات علمی, 45, 1, 1398, 41-49. doi: 10.30476/ijms.2019.45310
Khalili, Azadeh, Alipour, Shohreh, Fathalipour, Mohammad, Purkhosrow, Azar, Mashghoolozekr, Elaheh, Bayat, Gholamreza, Nekooeian, Ali Akbar. (1398). 'Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats', سامانه مدیریت نشریات علمی, 45(1), pp. 41-49. doi: 10.30476/ijms.2019.45310
Khalili, Azadeh, Alipour, Shohreh, Fathalipour, Mohammad, Purkhosrow, Azar, Mashghoolozekr, Elaheh, Bayat, Gholamreza, Nekooeian, Ali Akbar. Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats. سامانه مدیریت نشریات علمی, 1398; 45(1): 41-49. doi: 10.30476/ijms.2019.45310
Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats
1Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran; Department of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
2Department of Quality Control, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Pharmacology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
4Cardiovascular Pharmacology Research Lab, Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
5Department of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
6Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, and Cardiovascular Pharmacology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Liposomes constitute a promising drug delivery vehicle, and are believed to improve drugs’ effectiveness. This study was aimed to compare antihypertensive and vascular modifying activities of liposomal and non-liposomal forms of ascorbic acid. Methods: Forty-nine male Sprague-Dawley rats were randomly divided into seven groups (n=7): A sham vehicle-receiving (Sham-veh), hypertensive (HTN), vehicle-receiving hypertensive (HTN-Veh), two liposomal Ascorbic acid-treated hypertensive at 50 or 100 mg/kg/day (LVC-50 and LVC-100), and two non-liposomal Ascorbic acid-treated hypertensive at 50 or 100 mg/kg/day (VC-50 and VC-100). Systolic blood pressure (SBP) and heart rate (HR) were measured weekly; after 4 weeks, dose-responses to phenylephrine (PE) in the absence and presence of nitro-L-arginine methyl ester (L-NAME), acetylcholine (Ach), and sodium nitroprusside (SNP) were obtained on aortic rings. Data were analyzed with one-way ANOVA and Duncan’s multiple range test at a P value of Results: Compared to the non-liposomal form, the liposomal one was associated with more prominent effects on the final SBP. Both forms of Ascorbic acid decreased SBP dose-dependently. The basal and stimulated release of Nitric Oxide (NO) was significantly recovered by both forms of Ascorbic acid. The PE maximal responses were not significantly different between the liposomal and non-liposomal groups (P=0.08). Although the Emax of Ach-relaxation response was not different in two preparation forms, Ach-relaxation response induced a lower concentration of the liposomal form of Ascorbic acid (P=0.03) Conclusion: The liposomal Ascorbic acid exhibited relaxation activity in significantly lower concentrations. The observed effects were partly mediated by the increased basal release of NO.
Ajay M, Achike FI, Mustafa MR. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Pharmacol Res. 2007;55:385-91. doi: 10.1016/j.phrs.2007.01.007. PubMed PMID: 17317209.
Park KH, Park WJ. Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches. J Korean Med Sci. 2015;30:1213-25. doi: 10.3346/jkms.2015.30.9.1213. PubMed PMID: 26339159; PubMed Central PMCID: PMCPMC4553666.
Khalili A, Nekooeian AA, Khosravi MB, Fakher S. Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats. Int J Exp Pathol. 2012;93:210-7. doi: 10.1111/j.1365-2613.2012.00811.x. PubMed PMID: 22458508; PubMed Central PMCID: PMCPMC3385919.
Khalili A, Khosravi MB, Nekooeian AA. The effects of aqueous extract of vaccinium arctostaphylos leaves on blood pressure in renal hypertensive rats. Iran Red Crescent Med J. 2011;13:123-7. PubMed PMID: 22737446; PubMed Central PMCID: PMCPMC3371910.
Naregal GV, Devaranavadagi BB, Patil SG, Aski BS. Elevation of Oxidative Stress and Decline in Endogenous Antioxidant Defense in Elderly Individuals with Hypertension. J Clin Diagn Res. 2017;11:BC09-BC12. doi: 10.7860/JCDR/2017/27931.10252. PubMed PMID: 28892880; PubMed Central PMCID: PMCPMC5583849.
Khalili A, Nekooeian AA, Khosravi MB. Oleuropein improves glucose tolerance and lipid profile in rats with simultaneous renovascular hypertension and type 2 diabetes. J Asian Nat Prod Res. 2017;19:1011-21. doi: 10.1080/10286020.2017.1307834. PubMed PMID: 28347166.
Nekooeian AA, Khalili A, Khosravi MB. Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats. Iran J Med Sci. 2014;39:51-9. PubMed PMID: 24453394; PubMed Central PMCID: PMCPMC3895895.
Al-Khudairy L, Flowers N, Wheelhouse R, Ghannam O, Hartley L, Stranges S, et al. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;3:CD011114. doi: 10.1002/14651858.CD011114.pub2. PubMed PMID: 28301692; PubMed Central PMCID: PMCPMC6464316.
Kuwabara A, Nakade M, Tamai H, Tsuboyama-Kasaoka N, Tanaka K. The association between vitamin E intake and hypertension: results from the re-analysis of the National Health and Nutrition Survey. J Nutr Sci Vitaminol (Tokyo). 2014;60:239-45. PubMed PMID: 25297612.
Mozafari M, Nekooeian AA, Panjeshahin MR, Zare HR. The effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms. Iran J Med Sci. 2015;40:152-60. PubMed PMID: 25821295; PubMed Central PMCID: PMCPMC4359935.
Nekooeian AA, Khalili A, Khosravi MB. Effects of oleuropein in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms. J Asian Nat Prod Res. 2014;16:953-62. doi: 10.1080/10286020.2014.924510. PubMed PMID: 24954237.
Hoitink A. Research on the influence of vitamin C administration on the human organism, in particular in connection with the working capacity. Verh Nederlands Inst Praevent. 1946;4:62-3.
Block G, Jensen CD, Norkus EP, Hudes M, Crawford PB. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutr J. 2008;7:35. doi: 10.1186/1475-2891-7-35. PubMed PMID: 19091068; PubMed Central PMCID: PMCPMC2621233.
Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem. 2001;218:97-103. PubMed PMID: 11330844.
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102. doi: 10.1186/1556-276X-8-102. PubMed PMID: 23432972; PubMed Central PMCID: PMCPMC3599573.
Hickey S, Roberts HJ, Miller NJ. Pharmacokinetics of oral vitamin C. Journal of Nutritional & Environmental Medicine. 2008;17:169-77. doi: 10.1080/13590840802305423.
Parhizkar E, Rashedinia M, Karimi M, Alipour S. Design and development of vitamin C-encapsulated proliposome with improved in-vitro and ex-vivo antioxidant efficacy. J Microencapsul. 2018;35:301-11. doi: 10.1080/02652048.2018.1477845. PubMed PMID: 29781344.
Council NR. Guide for the care and use of laboratory animals. 8th edition. Washington: National Academies Press; 2011.
Nekooeian A, Mashhoodi T. Solid plexiglass clips to induce reproducible renal hypertension in the rat. J Pharmacol. 2007;39:25. doi: 10.4103/0253-7613.30758.
Duarte DA, Silva KC, Rosales MA, Lopes de Faria JB, Lopes de Faria JM. The concomitance of hypertension and diabetes exacerbating retinopathy: the role of inflammation and oxidative stress. Curr Clin Pharmacol. 2013;8:266-77. PubMed PMID: 23173956.
Khalili A, Khosravi MB, Nekooeian AA. The effects of aqueous extract of vaccinium arctostaphylos leaves on blood pressure in renal hypertensive rats. Iran Red Crescent Med J. 2011;13:123-7. PubMed PMID: 22737446; PubMed Central PMCID: PMCPMC3371910.
Hendriks MG, Kam KL, Pijl AJ, Pfaffendorf M, van Zwieten PA. The effects of hypertension and diabetes mellitus on the vascular reactivity of resistance arteries. Blood Press. 1993;2:69-76. PubMed PMID: 8193736.
Wong CM, Yao X, Au CL, Tsang SY, Fung KP, Laher I, et al. Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vascul Pharmacol. 2006;44:290-8. doi: 10.1016/j.vph.2005.12.005. PubMed PMID: 16542882.
Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr. 1993;57:213-7. doi: 10.1093/ajcn/57.2.213. PubMed PMID: 8424391.
Pattni BS, Chupin VV, Torchilin VP. New Developments in Liposomal Drug Delivery. Chem Rev. 2015;115:10938-66. doi: 10.1021/acs.chemrev.5b00046. PubMed PMID: 26010257.
Nekooeian AA, Khalili A, Khosravi MB. Oleuropein offers cardioprotection in rats with simultaneous type 2 diabetes and renal hypertension. Indian J Pharmacol. 2014;46:398-403. doi: 10.4103/0253-7613.135951. PubMed PMID: 25097277; PubMed Central PMCID: PMCPMC4118532.